CCGs facing 'significant financial risk' after generic drug price surge

Hand with pills

Clinical commissioning groups are facing “significant financial risk” this financial year due to supply issues pushing up the prices they have to pay for generic drugs.

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access